Ana Lucrecia Woodward

Array ( [id] => 7677123 [patent_doc_number] => 20040152703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Bisaryl derivatives having FSH modulatory activity' [patent_app_type] => new [patent_app_number] => 10/623640 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43506 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152703.pdf [firstpage_image] =>[orig_patent_app_number] => 10623640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645482 [patent_doc_number] => 07119093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => '3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition' [patent_app_type] => utility [patent_app_number] => 10/623971 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3725 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119093.pdf [firstpage_image] =>[orig_patent_app_number] => 10623971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281369 [patent_doc_number] => 20040063746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives' [patent_app_type] => new [patent_app_number] => 10/622687 [patent_app_country] => US [patent_app_date] => 2003-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19362 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063746.pdf [firstpage_image] =>[orig_patent_app_number] => 10622687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009561 [patent_doc_number] => 06900323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'Antiviral azaindole derivatives' [patent_app_type] => utility [patent_app_number] => 10/621139 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27574 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900323.pdf [firstpage_image] =>[orig_patent_app_number] => 10621139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291027 [patent_doc_number] => 20040110745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Therapeutic chroman compounds' [patent_app_type] => new [patent_app_number] => 10/466565 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34840 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110745.pdf [firstpage_image] =>[orig_patent_app_number] => 10466565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7336917 [patent_doc_number] => 20040132694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Il-8 receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/466383 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10648 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132694.pdf [firstpage_image] =>[orig_patent_app_number] => 10466383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355796 [patent_doc_number] => 20040048897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Il-8 receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/466382 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13971 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048897.pdf [firstpage_image] =>[orig_patent_app_number] => 10466382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387269 [patent_doc_number] => 20040029889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors' [patent_app_type] => new [patent_app_number] => 10/398636 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16557 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029889.pdf [firstpage_image] =>[orig_patent_app_number] => 10398636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7362335 [patent_doc_number] => 20040014769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => '4-(2-Pyridyl)piperazines having 5HT7 receptor agonist activity' [patent_app_type] => new [patent_app_number] => 10/617967 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6661 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014769.pdf [firstpage_image] =>[orig_patent_app_number] => 10617967 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 654817 [patent_doc_number] => 07109186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/616031 [patent_app_country] => US [patent_app_date] => 2003-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62946 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109186.pdf [firstpage_image] =>[orig_patent_app_number] => 10616031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7435348 [patent_doc_number] => 20040266786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Compound eugenosedin-a and antidepressants protect against lipopolysaccharide-induced shock' [patent_app_type] => new [patent_app_number] => 10/610900 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 8727 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266786.pdf [firstpage_image] =>[orig_patent_app_number] => 10610900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7450480 [patent_doc_number] => 20040010037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Cyanophenyl derivative' [patent_app_type] => new [patent_app_number] => 10/608341 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22870 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010037.pdf [firstpage_image] =>[orig_patent_app_number] => 10608341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7404378 [patent_doc_number] => 20040023979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Process for making substituted thiazolyl-amino pyridines' [patent_app_type] => new [patent_app_number] => 10/607056 [patent_app_country] => US [patent_app_date] => 2003-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8916 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023979.pdf [firstpage_image] =>[orig_patent_app_number] => 10607056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281348 [patent_doc_number] => 20040063725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Novel n(phenylsulphonyl)glycine derivatives and their therapeutic use' [patent_app_type] => new [patent_app_number] => 10/451617 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25310 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063725.pdf [firstpage_image] =>[orig_patent_app_number] => 10451617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7241312 [patent_doc_number] => 20040158064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Prostaglandin endoperoxide H synthase biosynthesis inhibitors' [patent_app_type] => new [patent_app_number] => 10/464928 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 132070 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20040158064.pdf [firstpage_image] =>[orig_patent_app_number] => 10464928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136299 [patent_doc_number] => 20040044007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Indoline derivatives' [patent_app_type] => new [patent_app_number] => 10/601347 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6003 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20040044007.pdf [firstpage_image] =>[orig_patent_app_number] => 10601347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281337 [patent_doc_number] => 20040063714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Triazolo-pyridazine derivatives as ligands for GABA receptors' [patent_app_type] => new [patent_app_number] => 10/463075 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21710 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063714.pdf [firstpage_image] =>[orig_patent_app_number] => 10463075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225086 [patent_doc_number] => 20040072822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'N,N-disubstituted diazocycloalkanes' [patent_app_type] => new [patent_app_number] => 10/463222 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16306 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072822.pdf [firstpage_image] =>[orig_patent_app_number] => 10463222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225285 [patent_doc_number] => 20040072839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => '1-Phenylalkylpiperazines' [patent_app_type] => new [patent_app_number] => 10/463196 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37074 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072839.pdf [firstpage_image] =>[orig_patent_app_number] => 10463196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 386695 [patent_doc_number] => 07304064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => '1-[(indol-3-yl)carbonyl]piperazine derivatives' [patent_app_type] => utility [patent_app_number] => 10/518279 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14326 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/304/07304064.pdf [firstpage_image] =>[orig_patent_app_number] => 10518279 [rel_patent_id] =>[rel_patent_doc_number] =>)